-
Fitbit Has Potential For A Q3 Upside Surprise
Monday, October 17, 2016 - 12:13pm | 431Read More...Previewing Fitbit In (NYSE: FIT)'s third-quarter results, SunTrust said it sees scope for upside surprise from the company's guidance for a 15 percent sequential drop in third-quarter revenues based on expectations of 12.5 percent unit sales decline and a 1.5 percent decline in ASP. Rationale For...
-
Alibaba's Core Profitability Remains Strong, Near-Term Headwinds Notwithstanding
Wednesday, October 12, 2016 - 12:08pm | 435Read More...Previewing the fiscal second-quarter results of Alibaba Group Holding Ltd (NYSE: BABA), SunTrust noted that core profitability remains strong, despite the near-term investments headwinds. The firm sees strong investor sentiment and business momentum, based on the company's analyst day takeaways...
-
2 Reasons SunTrust Upgraded Corrections Corp Of America To Buy
Wednesday, October 12, 2016 - 11:21am | 111Read More...SunTrust’s Tobey Sommer upgraded Corrections Corp Of America (NYSE: CXW) to Buy with $20 price target on continued double-digit dividend and positive news flow to be mixed into the uniformly negative news of the last two months. “We now assume that out-of-state business with CA goes...
-
Impact From Samsung Issues Should Be Muted For Best Buy, GameStop
Wednesday, October 12, 2016 - 9:17am | 328Read More...Issues with Samsung Electronic’s (OTCMKTS: SSNLF) Note 7 are unlikely to have a significant impact on either Best Buy Co Inc (NYSE: BBY) or GameStop Corp. (NYSE: GME), SunTrust’s David Magee commented. Best Buy Analyst Magee mentioned that Best Buy should be able to “shrug...
-
Expect An In-Line Quarter From JD.com
Monday, October 10, 2016 - 11:01am | 372Read More...SunTrust expects an in-line quarter from JD.Com Inc(ADR) (NASDAQ: JD) on which the retailer Wal-Mart Stores, Inc. (NYSE: WMT) recently raised its stake to 10.8 percent from 5 percent. SunTrust's Robert "Bob" Peck expects third quarter GMV/Revenue/gross profit of RMB 151.5 billion/RMB 60.4 billion/...
-
SunTrust Cuts Target On Bristol-Myers As Opdivo Estimates Revised Lower
Monday, October 10, 2016 - 10:08am | 351Read More...After Bristol-Myers Squibb Co (NYSE: BMY) disclosed disappointing study results of its Opdivo, SunTrust has reduced the price target on the company's shares from $68 to $62 on lower EPS estimates for the year 2017 and 2018. However, the firm maintains its Hold rating on the stock. Analyst John...
-
SunTrust's Bob Peck Has Higher Confidence In eBay's Turnaround, Price Target Raised To $33
Monday, October 10, 2016 - 9:50am | 541Read More...EBay Inc (NASDAQ: EBAY) is expected to report its third-quarter financials on October 19, and SunTrust's Robert "Bob" Peck sees results largely in line with the Street while expressing confidence in the turnaround of the company. Following are Peck's key estimates for the third quarter: "GMV at $...
-
Olive Garden Dominates The Darden Story Post Earnings
Wednesday, October 5, 2016 - 1:22pm | 269Read More...Darden Restaurants, Inc. (NYSE: DRI) is coming off an earnings and revenue beat and a raised guidance outlook for the rest of the year. A primary contributor to the strength of the chain-restaurant operator has been Olive Garden's turnaround story. In Q1, Olive Garden outperformed the industry by...
-
Ariad Pharmaceuticals Expected To See Clinical Catalysts
Wednesday, October 5, 2016 - 1:21pm | 319Read More...SunTrust Robinson Humphrey sees potential upside of 65 percent in Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) given clinical catalysts and the company could be a takeover target. Ariad's lead product Iclusig is a potent chronic myeloid leukemia (CML), drug, with the potential for broader use...
-
Sell-Side Sentiment On Twitter Following Buyout Chatter Has Not Been Positive
Thursday, September 29, 2016 - 9:49am | 834Read More...It has now been almost a full week since CNBC's David Faber reported that Twitter Inc (NYSE: TWTR) is engaged in discussions with potential acquirers over a sale of itself. The initial report last Friday singled out salesforce.com, inc. (NYSE: CRM) and Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) as...
-
Sarepta Shares Continue Rally As Analysts Flip To Positive
Tuesday, September 20, 2016 - 3:04pm | 426Read More...The craze for Sarepta Therapeutics Inc (NASDAQ: SRPT) shares continued into its second day, gaining about 15 percent on Tuesday. The stock nearly doubled from the $28.15 recorded on September 16. Two catalysts likely responsible for this rally include the FDA approval for the company's Duchenne...
-
SunTrust On Sarepta Therapeutics: FDA Likely To Deny Approval For Eteplirsen
Wednesday, September 14, 2016 - 3:27pm | 390Read More...SunTrust said the "logical decision" for the FDA would be to deny approval for Sarepta Therapeutics Inc (NASDAQ: SRPT)'s Eteplirsen drug for the treatment of Duchenne Muscular Dystrophy. DMD is a genetic disorder caused by an absence of dystrophin, a protein that helps keep muscle...
-
SunTrust Downgrades Belden As 'Catalysts Seem More Negative'
Wednesday, September 7, 2016 - 12:16pm | 309Read More...Close on the heels of Belden Inc. (NYSE: BDC) shares hitting a 52-week high of $75.91 on September 2, SunTrust analyst William Stein downgraded the stock to a Neutral rating. The comments come in the wake of the stock recording more than 50 percent gain in the year-to-date period ending September 6...
-
The Impact Of Instagram Stories, Olympics And Political Spending On Social Media Stocks
Tuesday, September 6, 2016 - 10:47am | 402Read More...The world of social media is evolving on a seemingly weekly basis, and investors in the space must keep up with the latest trends to stay ahead of the game. SunTrust analyst Robert "Bob" Peck recently discussed three topics that have had a major impact on the social media space in the second half...
-
Tilly's Q2 Beat Impresses SunTrust
Thursday, August 25, 2016 - 12:25pm | 195Read More...SunTrust Robinson Humphrey provided its outlook on Tilly's Inc (NYSE: TLYS). The analysts reiterated their Neutral rating and lifted the price target to $8 from $6.50, following solid Q2 results. The company reported Q2 EPS of $0.05, well above both STRH and Street of $(0.03) and 5/25...













